Barclays, Goldman Sachs, JP Morgan and Morgan Stanley issued bullish rating on Omada Health stock saying the virtual‑care provider could capture more of the large market for diabetes, hypertension and ...

In another sign of recovery in digital health investing, Omada Health has priced an initial public offering (IPO) of $19 per share, looking for $150 million in proceeds and a valuation upwards of ...